ExpreS2ion Biotech Holding AB (publ)
EXPRS2
Rank in Stocks
#33787
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its... Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Share Price
$0.09325189
Last synced: 2026-11-09
Market Cap
$237.89K
Change (1 day)
-0.60%
Change (1 year)
-94.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Category
Healthcare
Operating Margin for ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Operating Margin as of November 2026 TTM: -1,674.43%
According to ExpreS2ion Biotech Holding AB (publ)'s latest financial reports, its current operating margin (TTM) is -1,674.43%. At the end of 2025 the company had an operating margin of -1,444.35%.
Operating Margin history for ExpreS2ion Biotech Holding AB (publ) from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,674.43% | 15.93% |
| 2025 | -1,444.35% | -35.71% |
| 2024 | -2,246.76% | 49.48% |
| 2023 | -1,503.05% | -40.09% |
| 2022 | -2,508.97% | 534.23% |
| 2021 | -395.59% | -33.31% |
| 2020 | -593.19% | 403.43% |
| 2019 | -117.83% | -42.76% |
| 2018 | -205.86% | 76.34% |
| 2017 | -116.74% | -40.73% |
| 2016 | -196.95% | 0.00% |
| 2015 | 0.00% | -100.00% |
| 2014 | 4.22% | -59.15% |
| 2013 | 10.33% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.02% |
US
|
|
| -149.01% | -99.91% |
US
|
|
| 25.57% | -100.02% |
AU
|
|
| 31.23% | -100.02% |
BE
|
|
| 29.35% | -100.02% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ExpreS2ion Biotech Holding AB (publ)'s operating margin
What is ExpreS2ion Biotech Holding AB (publ)'s operating margin?
ExpreS2ion Biotech Holding AB (publ)'s operating margin is -1,674.43%, as of Nov 2026.
What was ExpreS2ion Biotech Holding AB (publ)'s operating margin in 2025?
In 2025, ExpreS2ion Biotech Holding AB (publ)'s operating margin was -1,444.35%, compared with -2,246.76% in 2024.
How has ExpreS2ion Biotech Holding AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, ExpreS2ion Biotech Holding AB (publ)'s operating margin was highest in 2021 (-395.59%) and lowest in 2022 (-2,508.97%).
How does ExpreS2ion Biotech Holding AB (publ)'s operating margin compare with similar companies?
ExpreS2ion Biotech Holding AB (publ)'s operating margin (-1,674.43%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.